Generic Name
Fusidic acid dry suspension

Reg. No.
 HC20060017 

Indication
 Fusidic acid dry suspension is indicated for the treatment of infections caused by susceptible organisms, especially staphylococci, such as osteomyelitis, septicemia, endocarditis, cystic fibrosis, pneumonia, skin and soft tissue infections, surgical and traumatic wound infections. 

Specification
 0.25g (calculated as C31H48O6) 

Package
 In PET/AL/PE sachet, six or twelve sachets per box. 

Manufacture
 Hong Kong